Home >> Diagnostics >> Consumer Goods >>

Global Irritable Bowel Syndrome Market 2015-2019

Published: Nov-2014 | Format: PDF | Technavio | Number of pages: 86 | Code: MRS - 1549

About Irritable Bowel Syndrome

Irritable bowel syndrome is a common disorder of the digestive system causing abdominal cramps, discomfort, bloating, constipation, and diarrhea. Inflammatory bowel disease, which is a chronic disease with recurrent immune response and inflammation of the GI tract, is sometimes confused with irritable bowel syndrome. The symptoms of irritable bowel syndrome generally appear in a patient aged around 30 years. According to the CDC, prominent symptoms of irritable bowel syndrome include severe bloating, severe stomach cramps or abdominal pain, lower back pain, groin pain, heartburn, acidity, shooting pain in the legs, and lightheadedness after eating.


TechNavio's analysts forecast the Global Irritable Bowel Syndrome market to grow at a CAGR of 14.04 percent over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Irritable Bowel Syndrome market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various generic and branded therapies used in the treatment of irritable bowel syndrome.

TechNavio's report, Global Irritable Bowel Syndrome Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Irritable Bowel Syndrome market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

• Americas

• APAC       

• EMEA

Key Vendors

• Actavis

• Astellas Pharma

• Nestle

• Takeda Pharmaceutical

Other Prominent Vendors


 • Abbott

• Alba Therapeutics

• Alfa Wassermann

• Alizyme

• Almirall

• AltheRx Pharmaceuticals

• Ardelyx

• AstraZeneca

• Bayer

• Bristol Myers Squibb

• Dainippon Sumitomo Pharma

• Dong-A Socio Holdings

• Drais Pharmaceuticals

• Dynogen

• gIcare Pharma

• GlaxoSmithKline

• Hanmi Pharmaceuticals

• ImmusanT

• Ironwood

• Janssen

• Lexicon Pharmaceuticals

• Menarini

• MicroDose Therapeutx

• Norgine

• Novartis

• Ocera Therapeutics

• Ono Pharmaceutical

• Par Pharmaceutical

• Pfizer

• Pharmos

• Protagonist Therapeutics

• RaQualia Pharma

• Rottapharm

• Salix

• Seldar Pharma

• Shire

• SK Chemicals

• SOFAR

• Synergy Pharmaceuticals

• Synthetic Biologics

• Tioga Pharmaceuticals

• Tsumura

• Yuhan

Market Driver

• Presence of Unmet Need

• For a full, detailed list, view our report

Market Challenge

• High Cost of Therapy

• For a full, detailed list, view our report

Market Trend

• Rise in Public Awareness

• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2018 and what will the growth rate be

• What are the key market trends

• What is driving this market

• What are the challenges to market growth

• Who are the key vendors in this market space

• What are the market opportunities and threats faced by the key vendors

• What are the strengths and weaknesses of the key vendors

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Product Profiles

04.1.1 Linzess

04.1.2 Irribow/Irribow OD

04.1.3 Lotronex

04.1.4 Amitiza

05. Market Research Methodology

05.1 Market Research Process

05.2 Research Methodology

06. Introduction

07. Market Landscape

07.1 Market Overview

07.2 Market Size and Forecast

07.3 Five Forces Analysis

08. Market Segmentation by Mechanism of Action

08.1 Guanylate Cyclase Receptor-C Agonist

08.2 5HT3 Antagonist

08.3 Chloride Channel Activator

08.4 Others

09. Market Segmentation by Dosage Form

09.1 Solid

09.2 Liquid

10. Market Segmentation by Indication

10.1 IBS-C

10.2 IBS-D

11. Market Segmentation by End User Gender

11.1 Female

11.2 Both

12. Geographical Segmentation

13. Rate of Incidence and Prevalence

14. Buying Criteria

15. Market Growth Drivers

16. Drivers and their Impact

17. Market Challenges

18. Impact of Drivers and Challenges

19. Market Trends

20. Trends and their Impact

21. Vendor Landscape

21.1 Competitive Scenario

21.1.1 Key News

21.1.2 Mergers and Acquisitions

21.2 Market Share Analysis 2014

21.2.1 Takeda

21.2.2 Nestle

21.2.3 Actavis

21.2.4 Astellas

21.3 Other and Future Prominent Vendors

22. Pipeline Portfolio

23. Key Vendor Analysis

23.1 Actavis

23.1.1 Key Facts

23.1.2 Business Description

23.1.3 Business Segmentation

23.1.4 Business Segmentation by Revenue 2012 and 2013

23.1.5 Sales by Geography

23.1.6 Business Strategy

23.1.7 Key Information

23.1.8 SWOT Analysis

23.2 Astellas Pharma

23.2.1 Key Facts

23.2.2 Business Overview

23.2.3 Product Segmentation

23.2.4 Product Segmentation by Revenue 2012 and 2013

23.2.5 Geographical Segmentation by Revenue 2013

23.2.6 Business Strategy

23.2.7 Recent Developments

23.2.8 SWOT Analysis

23.3 Nestlé

23.3.1 Key Facts

23.3.2 Business Overview

23.3.3 Business Segmentation by Revenue 2013

23.3.4 Business Segmentation by Revenue 2012 and 2013

23.3.5 Geographical Segmentation by Revenue 2013

23.3.6 Business Strategy

23.3.7 Recent Developments

23.3.8 SWOT Analysis

23.4 Takeda Pharmaceuticals

23.4.1 Key Facts

23.4.2 Business Overview

23.4.3 Business Segmentation by Revenue 2013

23.4.4 Business Segmentation by Revenue 2013

23.4.5 Geographical Segmentation by Revenue 2013

23.4.6 Business Strategy

23.4.7 Recent Developments

23.4.8 SWOT Analysis

24. Other Reports in this Series


List of Exhibits:


Exhibit 1: Market Research Methodology
Exhibit 2: Global Irritable Bowel Syndrome Market 2014-2019 (US$ million)
Exhibit 3: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action
Exhibit 4: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action 2014
Exhibit 5: Global Irritable Bowel Syndrome Market Segmentation by Dosage Form
Exhibit 6: Global Irritable Bowel Syndrome Market Segmentation by Dosage Form 2014
Exhibit 7: Global Irritable Bowel Syndrome Market Segmentation by Indication
Exhibit 8: Global Irritable Bowel Syndrome Market Segmentation by Mechanism of Action 2014
Exhibit 9: Global Irritable Bowel Syndrome Market Segmentation by End User Gender
Exhibit 10: Global Irritable Bowel Syndrome Market Segmentation by End User Gender 2014
Exhibit 11: Global Irritable Bowel Syndrome Market by Geographical Segmentation 2014
Exhibit 12: Prevalence of Irritable Bowel Syndrome in Japanese Females, by Type
Exhibit 13: Prevalence of Irritable Bowel Syndrome in Japanese Males, by Type
Exhibit 14: Global Irritable Bowel Syndrome Market Share Analysis 2014
Exhibit 15: Pipeline Portfolio of the Drug Candidates for Irritable Bowel Syndrome
Exhibit 16: Clinical Trials of Irritable Bowel Syndrome Drugs by Geography
Exhibit 17: Clinical Trials of Irritable Bowel Syndrome Drugs by Geography
Exhibit 18: Percentage of Clinical Trial Molecules in Each Phase
Exhibit 19: Actavis: Business Segmentation 2013
Exhibit 20: Actavis: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 21: Actavis : Sales by Geography (in US$ million)
Exhibit 22: Astellas Pharma: Product Segmentation 2013
Exhibit 23: Astellas Pharma : Product Segmentation by Revenue  2012 and 2013 (US$ billion)
Exhibit 24: Astellas Pharma: Geographical Segmentation by Revenue 2013
Exhibit 25: Nestlé: Business Segmentation by Revenue 2013
Exhibit 26: Nestlé: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 27: Nestlé: Geographical Segmentation by Revenue 2013
Exhibit 28: Takeda Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 29: Takeda Pharmaceuticals: Business Segmentation by Revenue  2013 (US$ million)
Exhibit 30: Takeda Pharmaceuticals: Geographical Segmentation by Revenue 2013 

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing